Epstein barr virus-associated hodgkin lymphoma

Citations of this article
Mendeley users who have this article in their library.


Classical Hodgkin lymphoma (cHL) is a distinct clinical and pathological entity with heterogeneous genetic and virological features, with regards to Epstein–Barr virus (EBV) infection. The variable association of cHL with EBV infection is probably related to the different levels of patient immunosuppression, both locally in the tumour tissue and at the systemic level. This review paper focuses on EBV-related cHL highlighting pathogenetic and pathological features that may impact pathobiology-driven treatment for the affected patients.




Carbone, A., & Gloghini, A. (2018, June 1). Epstein barr virus-associated hodgkin lymphoma. Cancers. MDPI AG. https://doi.org/10.3390/cancers10060163

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free